Cardiovascular & Hematological Disorders-Drug Targets

Aims & Scope

Cardiovascular & Hematological Disorders-Drug Targets aims to cover all the latest and outstanding developments in the medicinal chemistry, pharmacology, molecular biology, genomics, and biochemistry of contemporary molecular targets involved in cardiovascular and hematological disorders, e.g., disease-specific proteins, receptors, enzymes, and genes. Each issue of the journal contains a series of in-depth/mini-reviews, original research articles, drug clinical trial studies, and guest-edited thematic issues written by leaders in the field covering a range of current topics on drug targets involved in cardiovascular and hematological disorders. As the discovery, identification, characterization, and validation of novel human drug targets for cardiovascular and hematological drug discovery continue to grow, this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.

Cardiovascular & Hematological Disorders-Drug Targets is an international, peer-reviewed journal on all aspects of cardiovascular and hematological disorders, published quarterly (print & online) by Bentham Science Publishers.